16 May 2016 | News | By BioSpectrum Bureau
Takeda appoints James Kehoe as CFO
Takeda Pharmaceutical Company Limited has announced the appointment of James Kehoe as Takeda's new Chief Financial Officer and Corporate Officer, effective on June 15, 2016. Kehoe will be based in Tokyo and will report directly to Christophe Weber, President & CEO of Takeda.
"James Kehoe's passion for transforming large organizations to achieve higher performance will hold him in good stead as he leads the Global Finance team to further elevate the company's business performance and help Takeda deliver its growth ambitions," said Christophe Weber, President & CEO of Takeda. "We also believe that James's values are very much aligned with Takeda's values and that his personal style will work well with the Takeda Executive Team and the Finance Leadership Team."
Kehoe is an accomplished finance executive from the Consumer Goods sector. He is a strong business leader, with a track record of improving operational business performance that includes process optimization.
He joins Takeda from Kraft Foods Group in the US, where he most recently held the role of CFO. Prior to that, he has held a number of finance-related positions spanning the course of more than 20 years, with assignments based in Germany, Switzerland and Italy. An Irish national, Kehoe holds a Bachelor of Commerce degree from the University College, Galway, Ireland, and an MSc in Finance from the University College Dublin, Ireland.